FDA Investigator Tamara S Rosbury
Tamara S Rosbury has conducted inspections on 52 sites in 3 countries as of 12 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
52
Last Inspection Date:
12 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Switzerland,
Canada
FDA Investigators that have inspected at least one site in common with Tamara S Rosbury:
Abby E Pelletier,
Aditi S Thakur,
Alice C Silva,
Allison A Rodriguez,
Althea A Williams,
Amber G Wardwell,
Angel Asoler Garcia,
Ashley M Whitehurst,
Brenda P King,
Byungja E Marciante,
Camerson E Moore,
Carla C Tuite,
Christine M Parmentier,
Christopher K Vantwuyver,
Chunchun Zhang,
Darin S Wiegers,
Daryl A Dewoskin,
David P Vanhouten,
Dawn M Braswell,
Diane M Biron,
Dolores Harper,
Dominic R Frasca,
Donahue,
Dorothy W Lee,
Edmund F Mrak, Jr,
Elizabeth B Griffin,
Eric C Schmitt,
Erin P Conlin,
Frederick F Razzaghi,
Garry H Stewart,
Gary J Hagan,
Gary L Zaharek,
George T Allen, Jr,
Gerard D Difiore,
James D Hildreth,
James H Tanner,
James P Finn,
James W Whitney,
Jason A Rossi,
Jeffrey J Thibodeau,
John A Sciacchitano,
Jonathan B Lewis,
Jonathan G Matrisciano,
Justine M Corson,
Katarzyna Plona,
Katelyn Astaub Zamperini,
Kim M Downing,
Kwong P Lee,
Laiza V Garcia,
Lauren B Brown,
Lauren M Lawrance,
Laurie B Frazier,
Marcia M Laughrey,
Mark E Chan,
Maryam Tabatabaie,
Matthew D Silverman,
Maura Rooney,
Maureen L Dreher,
Megan A Haggerty,
Michael G Mayfield,
Michael P Sweeney,
Minh D Phan,
Mutahar S Shamsi,
Nabil Nakhoul,
Nealie C Newberger,
Paul P Geraci,
Paul W Moy,
Philip H Lafleur,
Quynh H Strandberg,
Sandra P White,
Sara M Onyango,
Sean R Marcsisin,
Seth A Mailhot,
Shawn M Bogdan,
Slater K Bartlett,
Stephen C King,
Stephen C Smith,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Teddy Tom,
Terry C Kimball,
Thai T Duong,
Todd J Maushart,
Vidya B Pai,
William K Dagley,
Xiaojun Yan
Tamara S Rosbury's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more